Showing 4961-4980 of 8875 for: Cochrane Systematic Reviews Back
- Medication review in hospitalised patients to reduce morbidity and mortality
Cochrane Systematic Reviews, 23-Jan-2023
A medication review can be defined as a structured evaluation of a patient's medication conducted by healthcare professionals with the aim of optimising medication use and improving health outcomes. Optimising medication therapy though medication reviews
- Medications for daytime sleepiness in individuals with idiopathic hypersomnia
Cochrane Systematic Reviews, 25-May-2021
Idiopathic hypersomnia is a disorder of excessive daytime sleepiness, often accompanied by long sleep times or pronounced difficulty in awakening, in the absence of a known cause. The optimal treatment strategy for idiopathic hypersomnia is currently unkn
- Medications for increasing milk supply in mothers expressing breastmilk for their preterm hospitalised infants
Cochrane Systematic Reviews, 8-Feb-2012
Breastmilk remains the optimal form of enteral nutrition for term and preterm infants until up to six months postnatal age. Mothers of preterm infants who have not established suck feeds must express their breastmilk and often have difficulty in maintaini
- Medicinal and injection therapies for mechanical neck disorders
Cochrane Systematic Reviews, 21-May-2015
Controversy persists regarding medicinal injection therapies for mechanical neck disorders.
- Medicinal herbs for hepatitis C virus infection
Cochrane Systematic Reviews, 23-Oct-2001
Hepatitis C virus (HCV) infection is a serious health problem world-wide. Medicinal herbs are increasingly being used for hepatitis C.
- Meditation for adults with haematological malignancies
Cochrane Systematic Reviews, 3-Feb-2016
Malignant neoplasms of the lymphoid or myeloid cell lines including lymphoma, leukaemia and myeloma are referred to as haematological malignancies. Complementary and alternative treatment options such as meditation practice or yoga are becoming popular by
- Meditation therapies for attention-deficit/hyperactivity disorder (ADHD)
Cochrane Systematic Reviews, 11-May-2010
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common developmental disorders experienced in childhood and can persist into adulthood. The disorder has early onset and is characterized by a combination of overactive, poorly modulated b
- Meditation therapy for anxiety disorders
Cochrane Systematic Reviews, 10-Nov-2008
Anxiety disorders are characterised by long term worry, tension, nervousness, fidgeting and symptoms of autonomic system hyperactivity. Meditation is an age-old self regulatory strategy which is gaining more interest in mental health and psychiatry. Medit
- Mediterranean‐style diet for the primary and secondary prevention of cardiovascular disease
Cochrane Systematic Reviews, 13-Mar-2019
The Seven Countries study in the 1960s showed that populations in the Mediterranean region experienced lower coronary heart disease (CHD) mortality probably as a result of different dietary patterns. Later observational studies have confirmed the benefits
- Mefloquine for preventing malaria during travel to endemic areas
Cochrane Systematic Reviews, 30-Oct-2017
Mefloquine is one of four antimalarial agents commonly recommended for preventing malaria in travellers to malaria-endemic areas. Despite its high efficacy, there is controversy about its psychological side effects.
- Mefloquine for preventing malaria in non-immune adult travellers
Cochrane Systematic Reviews, 6-Nov-2009
Mefloquine is commonly prescribed to prevent malaria in travellers, and has replaced other drugs because Plasmodium falciparum is commonly resistant to them. However, mefloquine may be associated with neuropsychiatric harmful effects.
- Mefloquine for preventing malaria in pregnant women
Cochrane Systematic Reviews, 14-Nov-2018
The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine for malaria for all women who live in moderate to high malaria transmission areas in Africa. However, parasite resistance to sulf
- Megestrol acetate for treatment of anorexia‐cachexia syndrome
Cochrane Systematic Reviews, 28-Mar-2013
This is an updated version of a previously published review in The Cochrane Library (2005, Issue 2) on 'Megestrol acetate for the treatment of anorexia-cachexia syndrome'. Megestrol acetate (MA) is currently used to improve appetite and to increase weight
- Meglitinide analogues for type 2 diabetes mellitus
Cochrane Systematic Reviews, 18-Apr-2007
In type 2 diabetes mellitus, impairment of insulin secretion is an important component of the disease. Meglitinide analogues are a class of oral hypoglycaemic agents that increase insulin secretion, in particular, during the early phase of insulin release
- Melatonin and agomelatine for preventing seasonal affective disorder
Cochrane Systematic Reviews, 17-Jun-2019
Seasonal affective disorder (SAD) is a seasonal pattern of recurrent major depressive episodes that most commonly starts in autumn or winter and remits in spring. The prevalence of SAD depends on latitude and ranges from 1.5% to 9%. The predictable season
- Melatonin as add‐on treatment for epilepsy
Cochrane Systematic Reviews, 11-Aug-2016
This is an updated version of the original Cochrane review published in Issue 6, 2012.
- Melatonin for non-respiratory sleep disorders in visually impaired children
Cochrane Systematic Reviews, 3-Oct-2011
Exogenous melatonin helps in regulating the circadian rhythm and is widely used for the management of sleep disorders in visually impaired children.
- Melatonin for preoperative and postoperative anxiety in adults
Cochrane Systematic Reviews, 8-Dec-2020
Anxiety in relation to surgery is a well-known problem. Melatonin offers an alternative treatment to benzodiazepines for ameliorating this condition in the preoperative and postoperative periods.
- Melatonin for the prevention and treatment of jet lag
Cochrane Systematic Reviews, 22-Apr-2002
Jet lag commonly affects air travellers who cross several time zones. It results from the body's internal rhythms being out of step with the day-night cycle at the destination. Melatonin is a pineal hormone that plays a central part in regulating bodily r
- Melatonin for the promotion of sleep in adults in the intensive care unit
Cochrane Systematic Reviews, 10-May-2018
Patients in the intensive care unit (ICU) experience sleep deprivation caused by environmental disruption, such as high noise levels and 24-hour lighting, as well as increased patient care activities and invasive monitoring as part of their care. Sleep de
